Can the immunoblot be negative in early babesiosis?

Yes. Antibodies may not be detectable in the first week of illness, so a negative result early in the course does not exclude infection. Repeat serology or direct detection by blood smear or PCR is recommended when suspicion remains high.

Does a positive IgG result mean active infection?

Not necessarily. IgG can persist long after parasitaemia has cleared, so a positive IgG indicates exposure but does not distinguish active from resolved infection. Blood smear, PCR, and clinical symptoms are needed to confirm active disease.

Why is this test particularly important in asplenic or immunocompromised patients?

Babesiosis can be severe, prolonged, or life-threatening in patients without a spleen or with impaired immunity. Early detection is critical, though these patients may mount blunted antibody responses, making direct methods essential alongside serology.

How does Babesia co-infection with Lyme disease affect interpretation?

Babesia and Borrelia burgdorferi are transmitted by the same tick, so co-infection is common. Practitioners often order both Lyme and Babesia serology in endemic areas, and the presence of co-infection can complicate symptom presentation and treatment.

Are the results comparable to other laboratories?

No. IgeneX uses proprietary antigen preparation and interpretive criteria that differ from other laboratories and from standard two-tier Lyme serology. Serial testing should be performed at the same laboratory for consistency.

Is fasting required for this test?

No. The immunoblot does not require fasting, though noting the date of symptom onset and any recent antimicrobial therapy on the requisition aids interpretation.

How long does it take to receive results?

Results are typically available within seven to ten business days from specimen receipt at IgeneX, though turnaround may be longer during high-volume periods.

BML-LYM-006lyme tick borneUSA

Babesia ImmunoBlot IgG + IgM

The Babesia ImmunoBlot IgG + IgM detects antibodies to Babesia species antigens by Western blot, offering greater specificity than enzyme immunoassays. Ordered in suspected tick-borne babesiosis with compatible symptoms and exposure, it reveals IgM for recent/acute infection and IgG for past or ongoing exposure;

Biomarkers

Blood (serum)

Sample

7–10 business days

Turnaround

Fasting

What is the Babesia ImmunoBlot test?

The Babesia ImmunoBlot IgG + IgM test uses Western blot technology to detect and characterise antibodies against Babesia species antigens, offering a more specific serological method than standard enzyme immunoassays in patients suspected of tick-borne babesiosis. Babesiosis is an intraerythrocytic protozoan infection transmitted by Ixodes ticks — the same vector as Borrelia burgdorferi — and can present with fever, haemolytic anaemia, and constitutional symptoms that may be mistaken for viral illness or co-occur with Lyme disease. Because serology can be negative early in acute infection and because antibodies may persist long after clearance, the immunoblot is most informative when ordered in the appropriate clinical and epidemiological window: practitioners use it to investigate patients with compatible symptoms and tick exposure when direct detection by blood smear or PCR is inconclusive or unavailable, to assess for co-infection in confirmed Lyme disease, and to screen immunocompromised or asplenic patients in whom babesiosis can be severe. Interpretation of band patterns and isotype requires integration with exposure history, symptom timeline, and other laboratory findings rather than reliance on serology alone.

What does the Babesia ImmunoBlot test measure?

Babesia IgG(Babesia-specific Immunoglobulin G)

Range: Negative (no significant bands); positive defined by presence of IgeneX-proprietary band criteria.Optimal: Negative; absence of specific IgG bands indicates no serological evidence of Babesia exposure.Band pattern

Immunoglobulin G antibodies to Babesia species appear weeks after acute infection and can persist for months to years. IgG responses develop more slowly than IgM and represent either recent or past exposure. The immunoblot detects antibody binding to specific Babesia antigens separated by molecular weight, providing greater specificity than enzyme immunoassays by displaying the pattern of reactivity rather than a single optical density.

Detection of Babesia-specific IgG supports past or ongoing babesiosis. Because antibodies can persist long after parasitaemia has cleared, a positive IgG does not distinguish active from resolved infection; clinical context, blood-smear microscopy, and PCR are required to confirm active disease. IgG seropositivity in asymptomatic individuals may reflect past unrecognised infection or exposure in endemic regions.

Babesia IgM(Babesia-specific Immunoglobulin M)

Range: Negative (no significant bands); positive defined by presence of IgeneX-proprietary band criteria.Optimal: Negative; absence of specific IgM bands indicates no serological evidence of recent Babesia infection.Band pattern

IgM antibodies to Babesia typically appear within the first week of symptomatic infection and may decline over subsequent weeks, though in some patients IgM can persist for months. The immunoblot reveals the molecular-weight pattern of IgM reactivity, which may offer earlier serological detection than IgG and can signal acute or recent infection when interpreted with the clinical picture.

Babesia-specific IgM is a marker of recent or acute infection. Isolated IgM positivity in a patient with compatible symptoms and epidemiology (tick exposure in an endemic area, summer months) raises suspicion for early babesiosis, though confirmation with blood smear or PCR is recommended because IgM can also persist or appear in reactivation. False-positive IgM can occur with polyclonal B-cell activation or cross-reactive antibodies.

Why is the Babesia ImmunoBlot test ordered?

Evaluation of febrile illness with haemolytic anaemia, thrombocytopenia, or elevated lactate dehydrogenase in a patient with tick exposure in an endemic region (northeastern and upper midwestern United States, parts of Europe)
Suspected babesiosis when Giemsa-stained blood smears are negative or equivocal and molecular testing (PCR) is not immediately available
Investigation of persistent or relapsing symptoms in a patient with confirmed or suspected Lyme disease, to detect Babesia co-infection
Screening of immunocompromised or asplenic patients with tick exposure or compatible symptoms, in whom babesiosis can cause severe or prolonged illness
Evaluation of a blood donor or transfusion recipient with unexplained fever or haemolysis, given the risk of transfusion-transmitted babesiosis
Assessment of treatment response or serological trends in documented babesiosis, recognising that antibody titres decline slowly and may not normalise for months

Sample collection and turnaround

Sample type

Blood (serum)

Fasting required

Collection method

Venipuncture at patient service centre

Turnaround

7–10 business days

Collection notes

Phlebotomy required; serum is separated and shipped to IgeneX. No special preparation. For optimal interpretation, note the date of symptom onset and any prior treatment on the requisition.

Specimen requirements

Minimum 1.0 mL serum in a red-top or serum-separator tube. Avoid haemolysis; separate from cells within two hours of collection and refrigerate or freeze if shipping is delayed. Consult IgeneX for specific specimen-handling instructions.

What can affect Babesia ImmunoBlot results?

variableTiming of specimen collection relative to symptom onset

Antibodies may be absent in the first week of acute infection (the 'window period'), so a negative immunoblot early in illness does not exclude babesiosis; repeat serology or direct detection is required.

reducesImmunosuppression or asplenia

Patients with impaired humoral immunity or absent splenic function may mount blunted antibody responses, reducing test sensitivity; direct methods (blood smear, PCR) are essential in these populations.

variableCross-reactivity with other infections or autoimmune conditions

Polyclonal B-cell activation, malaria, or other parasitic infections can occasionally produce non-specific bands; the immunoblot's multi-antigen pattern helps distinguish true reactivity from background, but clinical correlation is essential.

elevatesPersistent antibodies after treated or spontaneously resolved infection

IgG and sometimes IgM can remain detectable for months to years post-infection, so a positive result does not confirm active disease without supporting clinical or parasitological evidence.

variableLaboratory-specific interpretive criteria

IgeneX uses proprietary antigen preparation and band-scoring algorithms that differ from reference or research criteria; results are not directly interchangeable with other laboratories or with standard two-tier Lyme serology.

What do Babesia ImmunoBlot results mean?

Elevated

A positive IgM immunoblot suggests recent or active Babesia exposure, while a positive IgG indicates prior or ongoing infection; both reactive supports recent infection with evolving response. Immunoblot banding is interpreted against the laboratory's scoring criteria and should be correlated with clinical presentation and, for active babesiosis, with blood smear or PCR.

Normal

Non-reactive IgG and IgM in a patient without compatible illness indicates no serological evidence of Babesia exposure. Serology cannot confirm active parasitaemia; smear and PCR are required to establish current infection.

Reduced

A negative or non-reactive immunoblot lowers the likelihood of Babesia exposure but does not exclude early infection before seroconversion, or infection with a species not represented by the assay antigens. Repeat or species-specific testing may be warranted where suspicion is high.

Note: Immunoblot detects antibody, not parasite, so it neither confirms nor excludes active babesiosis and cannot gauge parasite burden. Cross-reactivity between Babesia species and prior exposure can produce persistent IgG. Band interpretation is proprietary and laboratory-specific.

Frequently asked questions

IgM appears within the first week of infection and signals recent or acute babesiosis, while IgG develops later and can persist for months to years, indicating past or ongoing exposure. Both are interpreted together with clinical and epidemiological context.

How to access the Babesia ImmunoBlot test

The Babesia ImmunoBlot reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:

Krause PJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA): 2020 guideline on diagnosis and management of babesiosis. Clin Infect Dis. (2021)
Vannier EG, Krause PJ. Human babesiosis. N Engl J Med. (2012)
Wormser GP, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. (2006)
Leiby DA. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev. (2011)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.